29th Annual ROTH Conference
March 12-15, 2017
Ritz Carlton, Dana Point, CA
ROTH Capital Partners' 29th Annual Conference is one of the largest of its kind in the United States. With roughly 500 participating companies and over 4,000 attendees, Roth will feature presentations from hundreds of public and private companies in a variety of sectors including health care; technology, Internet and media; cleantech, industrial growth and solar; consumer; oil and gas/mining and minerals; and business services. The three-and-a-half day event will include company presentations and small group meetings, as well as panels, entertainment and more. This gathering of institutional investors, private equity investors, VCs, company executives and service providers has become a must attend event for anyone working in the small and mid-cap space. For more information visit www.Roth.com
KemPharm (NASDAQ: KMPH) is a clinical-stage specialty pharmaceutical company that discovers and develops new proprietary prodrugs in the United States. Its advanced product candidate is KP201/APAP, which consists of KP201 prodrug of hydrocodone formulated in combination with acetaminophen (APAP). The company is also developing KP201/APAP as an immediate release (IR) product candidate for the treatment of acute pain, as well as engages in designing KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain. For more information, visit the company's website at www.kenpharm.com.
Kite Pharma (KITE)
Kite Pharma (NASDAQ: KITE) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. The company aims to achieve its goal of providing rapid, long-term durable response and eliminating the burden of chronic care through the development of cancer immunotherapies. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information, visit the company's website at www.kitepharma.com.
Knowles (NYSE: KN) is a global supplier of advanced micro-acoustic, audio processing, and specialty component solutions, serving the mobile consumer electronics, communications, medical, military, aerospace, and industrial markets. Knowles uses its position in MEMS (micro-electro-mechanical systems) microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in smartphones, tablets, and wearables. The company's focus on the customer, combined with unique technology, proprietary manufacturing techniques, rigorous testing and global scale, enables it to deliver innovative solutions that optimize the user experience. For more information, visit the company's website at www.knowles.com.
Kona Grill (KONA)
Kona Grill (NASDAQ: KONA) features a global menu of contemporary American favorites, award-winning sushi, and specialty cocktails in an upscale casual atmosphere. Kona Grill owns and operates 45 restaurants, guided by a passion for quality food and exceptional service. Restaurants are located in 23 states and Puerto Rico. For more information, visit the company's website at www.konagrill.com.
Kopin (NASDAQ: KOPN) is a developer and provider of innovative wearable technologies and solutions for integration into head-worn computing and display systems to military, industrial and consumer customers. Kopin's technology portfolio includes ultra-small displays, optics, speech enhancement technology, system and hands-free control software, low-power ASICs, and ergonomically designed smart headset reference systems. The company's proprietary components and technology are protected by more than 300 global patents and patents pending. For more information, visit the company's website at www.kopin.com.
Kratos Defense & Security Solutions (KTOS)
Kratos Defense & Security Solutions (NASDAQ: KTOS) provides mission critical products, solutions and services primarily for the government and commercial customers. The company operates through three segments: Kratos Government Solutions, Unmanned Systems, and Public Safety & Security. The Kratos Government Solutions segment offers microwave electronic products; satellite communications; technical and training solutions; modular systems; and defense and rocket support services. The Unmanned Systems segment provides unmanned aerial, ground, seaborne and command, control and communications systems. For more information, visit the company's website at www.kratosdefense.com.
Lakeland Industries (LAKE)
Lakeland Industries (NASDAQ: LAKE) manufactures and sells a range of safety garments and accessories for the industrial and public protective clothing. The company offers limited use/disposable protective clothing; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and firefighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams. For more information, visit the company's website at www.lakeland.com.
Landec (NASDAQ: LNDC) designs, develops, manufactures and markets differentiated health and wellness products in food and biomaterials markets. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruits, and vegetables utilizing the BreatheWay specialty packaging technology for the retail grocery, club store, and food services industry under the Eat Smart and GreenLine brand names. The Food Export segment purchases and sells whole commodity fruit and vegetable products primarily to Asian markets. The Biomaterials segment sells products utilizing hyaluronan (HA), a naturally occurring polysaccharide that is distributed in the extracellar matrix of connective tissues in animals and humans. For more information, visit the company's website at www.landec.com.
Lannett Company (LCI)
Lannett Company (NYSE: LCI) develops, manufactures, packages, markets and distributes generic versions of brand pharmaceutical products in the United States. It offers solid oral, extended release, topical, nasal and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel and injectable dosages. The company provides its products for various medical indications comprising glaucoma, muscle relaxant, migraine, anesthetic, congestive heart failure, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, dryness of the mouth, gout, hypertension and gallstone. For more information, visit the company's website at www.lannett.com.
Leaf Group (LFGR)
Leaf Group (NYSE: LFGR) operates as a diversified Internet company worldwide. The company builds platforms across its media and marketplaces properties to enable community of creators to reach passionate audiences of various lifestyle categories. It provides content and media services, including media content, such as text articles, videos, photographs, and designed visual formats. Leaf Group publishes the media content in its owned and operated online properties across categories, including eHow.com, a do-it-yourself and how-to reference destination; Livestrong.com, a health and healthy living destination; and Cracked.com, a humor Website offering comedy-driven video series, text articles and blogs, as well as niche properties. For more information, visit the company's website at www.leafgroup.com.
LeMaitre Vascular (LMAT)
LeMaitre Vascular (NASDAQ: LMAT) develops, manufactures and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable less invasive removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins, and occlusion catheters that temporarily occlude blood flow. For more information, visit the company's website at www.lemaitre.com.
Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals (NASDAQ: LGND) is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Its commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for the treatment of multiple myeloma; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. For more information, visit the company's website at www.ligand.com.
LightPath Technologies (LPTH)
LightPath Technologies (NASDAQ: LPTH) designs, develops, manufactures and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, infrared aspheric lenses, GRADIUM glass lenses, and other optical materials used to produce products that manipulate light. Its products are used in various industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries. LightPath sells its products directly to customers in North America and China, as well as through distributors and channel partners in Europe, the United States, and internationally. For more information, visit the company's website at www.lightpath.com.
Limbach Holdings (LMB)
Limbach Holdings (NASDAQ: LMB) provides commercial specialty contractor services in the United States. The company provides services in the areas of HVAC (heating, ventilation, and air-conditioning), plumbing, electrical and building controls for the design and construction of new and renovated buildings, as well as maintenance services and equipment upgrades. Its facility services comprise mechanical construction, HVAC service and maintenance, energy audits and retrofits, engineering and design build, constructability evaluation, equipment and materials selection, offsite/prefab construction, and sustainable building solutions and practices. For more information, visit the company's website at www.limbachinc.com.
Limoneira (NASDAQ: LMNR) operates as an agribusiness and real estate development company in the United States and internationally. The Lemon Operations segment grows, processes, packs, markets and sells lemons directly to food service, wholesale, and retail customers, as well as packs lemons grown by others. The Other Agribusiness segment grows avocado; oranges; and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, pistachios, olives, and wine grapes. The Rental Operations segment rents residential housing units; and commercial properties. For more information, visit the company's website at www.limoneira.com.
Lion Biotechnologies (LBIO)
Lion Biotechnologies (NASDAQ: LBIO) is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is LN-144, an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) that is in phase II clinical trial, which are T cells derived from patients' tumors for the treatment of patients with refractory metastatic melanoma. It is also developing LN-145 to treat cervical and head and neck cancers. The company has a patent license agreement with the National Institutes of Health to develop, manufacture and commercialize TIL therapies. For more information, visit the company's website at www.lbio.com.
Lipocine (NASDAQ: LPCN) is a specialty pharmaceutical company that develops pharmaceutical products using its oral drug delivery technology in the areas of men's and women's health. The company offers a portfolio of proprietary product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate, LPCN 1021, an oral testosterone replacement therapy designed for twice-a-day dosing that has completed Phase 3 testing. The company's pipeline candidates also include LPCN 1111, a next generation oral testosterone therapy product with once daily dosing that is in phase 2 testing. For more information, visit the company's website at www.lipocine.com.
LivePerson (NASDAQ: LPSN) provides mobile and online messaging technologies that power digital communication between brands and consumers in the United States, in the United Kingdom, the Asia-Pacific, Latin America and Western Europe. The Business segment facilitates real-time online interactions, such as chat, voice, messaging, and content delivery, across multiple channels and screens for corporations of all sizes. The Consumer segment facilitates online transactions between independent service providers and individual consumers seeking information and knowledge via mobile and online messaging. Its cloud-based platform is LiveEngage, which enables businesses to create a connection with consumers by offering messaging as a preferred channel of communication. For more information, visit the company's website at www.liveperson.com.
LM Funding America (LMFA)
LM Funding America (NASDAQ: LMFA) operates as a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida, as well as in the states of Washington, Colorado and Illinois. The company offers funding to associations by purchasing their rights under delinquent accounts that are selected by the associations arising from unpaid association assessments. It is also involved in the business of purchasing delinquent accounts on various terms tailored to suit each association's financial needs, including under its New Neighbor Guaranty program. For more information, visit the company's website at www.lmfunding.com.
Lonestar Resources (LONE)
Lonestar Resources (NASDAQ: LONE) is an independent oil and gas company that engages in the acquisition, development and production of unconventional resources in the United States. The company primarily focuses on Eagle Ford Shale properties that cover an area of 35,000 net acres in Texas counties. It also holds interests in an early-stage project in the Bakken Petroleum System that covers an area of 34,163 net acres in the Bakken, Three Forks, and Lower Lodgepole formations located in the Roosevelt County, Montana. The company is based in Fort Worth, Texas. For more information, visit the company's website at www.lonestarresources.com.
LRAD (NASDQ: LRAD) designs, develops and commercializes directed sound technologies and products in North and South America, Europe, the Middle East and Asia. It develops directed acoustic products that beam, focus and control sound over short and long distances. The company offers directional and omnidirectional sound products, which are used for communication and deterring threats over distances. It offers Long Range Acoustic Device primarily for government, military, law enforcement, homeland and international security, private and commercial security, border security, maritime security, and wildlife preservation and control markets. For more information, visit the company's website at www.lradx.com.
Lumenpulse (OTC: LMPLF) designs, develops, manufactures and sells light emitting diode (LED) lighting solutions for commercial, institutional and urban environments in Canada, the United States, and the United Kingdom. It offers cover and down light, interior linear system, light pixel, linear projector, pendant, sign light, submersible, task light, track spots and projector products. The company also sells LED products for accent, cove, task, flood and general lighting projects, grazing, media façade, orientation and signage, and submersible projects. It markets its products to third-party agents, electrical wholesale distributors and value-added resellers. For more information, visit the company's website at www.lumenpulse.com.
Lydall (NYSE: LDL) designs, manufactures and markets specialty engineered filtration media, industrial thermal insulating solutions, and automotive thermal and acoustical barriers for filtration/separation and thermal/acoustical applications worldwide. The Performance Materials segment offers filtration media solutions for air, fluid power and industrial applications. The Technical Nonwovens segment offers non-woven felt media and filter bags for industrial air and liquid filtration applications. The Thermal/Acoustical Metals segment provides engineered products for the transportation sector to thermally shield sensitive components from high heat, improve exhaust gas treatment, and lower harmful emissions, as well as assist to reduce powertrain and road noise. For more information, visit the company's website at www.lydall.com.
MacroGenics (NASDAQ: MGNX) is a biopharmaceutical company focused on discovering and developing antibody-based therapeutics for the treatment of cancer primarily by modulating the human immune system, as well as various autoimmune disorders and infectious diseases. Its advanced clinical product candidate is Margetuximab, a monoclonal antibody that is in Phase III clinical trial, which targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers. The company also develops Enoblituzumab, an antibody that is in phase 1 clinical trial as monotherapy in multiple dose expansion cohorts; and MGD006, a DART molecule that targets CD123 and CD3. For more information, visit the company's website at www.macrogenics.com.
Madrigal Pharmaceuticals (MDGL)
Madrigal Pharmaceuticals (NASDAQ: MDGL) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapies for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, which has completed Phase I single and multiple dose trials, an orally administered and small-molecule liver-directed selective thyroid hormone receptor-beta agonist for use in the treatment of nonalcoholic steatohepatitis (NASH), and heterozygous and homozygous familial hypercholesterolemia (FH) to lower LDL cholesterol, triglyceride levels, and Lp(a). For more information, visit the company's website at www.madrigalpharma.com.
MAG Silver (MAG)
MAG Silver (NYSE: MAG) is an exploration and development company that focuses on acquiring, exploring, and development of district scale projects located primarily in the Mexican Silver Belt. It explores for copper, gold, silver, lead and zinc deposits. The company has 44 percent interests in the Juanicipio project comprising a single concession covering 7,679.21 hectares located in central Zacatecas State, Mexico. It owns 100 percent interests in the Cinco de Mayo property consisting of 29 concessions located in the Municipio de Buenaventura, Chihuahua, Mexico; and the Guigui located in the Santa Eulalia Mining District of Chihuahua City, Mexico. For more information, visit the company's website at www.magsilver.com.
Magal Security Systems (MAGS)
Magal Security Systems (NASDAQ: MAGS) develops, manufactures and sells safety, security, site management, and intelligence gathering and compilation of physical and cyber solutions and products worldwide. The company offers perimeter security products that enable customers to monitor, limit and control access by unauthorized personnel to specific regions or areas. Its perimeter security systems include hybrid perimeter intrusion detection systems with physical barrier; fence mounted vibration detection systems; detection grids, gates and fences to protect water passages, VIP residences, and other outdoor applications; and buried cable sensors, electrical field disturbance sensors, and microwave sensors. For more information, visit the company's website at www.magal-s3.com.
Manitex International (MNTX)
Manitex International (NASDAQ: MNTX) provides engineered lifting and loading products worldwide. The Lifting Equipment segment designs, manufactures and distributes boom trucks and crane products. The ASV segment manufactures and sells compact rubber tracked and skid steer loaders for use in the site clearing, general construction, forestry, and golf course maintenance and landscaping industries. The Equipment Distribution segment distributes rough terrain and truck cranes used primarily for infrastructure development and commercial construction applications. For more information, visit the company's website at www.manitexinternational.com.
MannKind (NASDAQ: MNKD) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with Type 1 and Type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California. For more information, visit the company's website at www.mannkindcorp.com.
Marathon Patent Group (MARA)
Marathon Patent Group (NASDAQ: MARA) acquires and monetizes patents primarily in the United States. The company is involved in the acquisition of patents and patent rights from their owners ranging from individual inventors to Fortune 500 companies; and monetization of its patents and patent rights by entering into license discussions, and settlement and license agreements. As of December 31, 2015, it owned 327 patents and patent rights, and 12 patent applications in various technologies, markets, and countries. The company was formerly known as American Strategic Minerals Corporation and changed its name to Marathon Patent Group, Inc. in February 2013. For more information, visit the company's website at www.marathonpg.com.
Marchex (NASDAQ: MCHX) operates as an advertising analytics company operating through its Call-driven and Archeo segments. Its products include Marchex Call Analytics, an analytics technology platform that provides data and insights to measure the performance of mobile, online, and offline advertising for advertisers and small business resellers; and Marchex Call Analytics for Search, a product for search marketers that drive phone calls from search campaigns, as well as attributes inbound phone calls made directly from paid search ads and landing pages to a keyword. For more information, visit the company's website at www.marchex.com.
Marina Biotech (MRNA)
Marina Biotech (OTC: MRNA) discovers and develops nucleic acid-based therapeutics for rare and orphan diseases. The company's portfolio includes single and double-stranded nucleic acid therapeutics, including siRNAs, microRNA mimics, antagomirs, and antisense compounds that are intended to trigger various RNA-based mechanisms of actions, such as RNA interference, microRNA replacement therapy, microRNA inhibition, and mRNA translational inhibition. It also focuses on patients with familial adenomatous polyposis, a rare hereditary disease; myotonic dystrophy, a disease that affects muscles and other organs in the body; and Duchenne muscular mystrophy that occurs primarily in boys, as well as to treat diseases associated with various anatomical systems. For more information, visit the company's website at www.marinabio.com.
Masimo (NASDAQ: MASI) is a medical technology company that develops, manufactures and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. For more information, visit the company's website at www.masimo.com.
MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company's mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace; and as a website at massroots.com. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars, and stickers; and MassRoots for Business, a free online portal for dispensaries to schedule posts, view analytics, and gain insights into followers. For more information, visit the company's website at www.massroots.com.
Mast Therapeutics (MSTX)
Mast Therapeutics (NYSE: MSTX) is a clinical-stage biopharmaceutical company that develops therapies for serious or life-threatening diseases with significant unmet needs. The company's lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of heart failure with preserved ejection fraction. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. For more information, visit the company's website at www.masttherapeutics.com.
Mateon Therapeutics (MATN)
Mateon Therapeutics (NASDAQ: MATN) is a biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent, which has completed Phase II clinical trial for treating recurrent ovarian cancer; and in Phase II clinical trial for treating gastrointestinal neuroendocrine tumors. The company also develops OXi4503 that is in Phase I/II clinical trial stage for treating patients with relapsed or refractory acute myelogenous leukemia or myelodysplastic syndromes. For more information, visit the company's website at www.mateon.com.
Matinas BioPharma (MTNB)
Matinas BioPharma (OTC: MTNB) is a clinical-stage biopharmaceutical company that focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections. The company develops orally delivered therapeutics based on a proprietary, lipid crystal drug delivery platform called cochleate delivery technology. Its lead product candidate is MAT 2203, an oral formulation of the broad spectrum anti-fungal drug amphotericin B that is in Phase II study for the treatment of fungal infections. The company is also involved in developing MAT2501, an orally-administered, encochleated formulation of amikacin for acute bacterial infections, including non-tuberculous mycobacterium (NTM) and multi-drug resistant gram negative bacterial infections. For more information, visit the company's website at www.matinasbiopharma.com.
Mattersight (NASDAQ: MATR) provides behavioral analytics services in the United States. The company provides predictive behavioral routing, performance management, quality assurance, predictive analytics, and marketing managed services that analyzes and predicts customer behavior based on the language exchanged between agents and customers during brand interactions to enhance customer satisfaction and retention, employee engagement, and operating efficiency. It serves companies in the healthcare, insurance, financial service, technology, telecommunication, cable, utility, education, hospitality and government industries. The company was formerly known as eLoyalty Corporation and changed its name to Mattersight Corporation in May 2011. For more information, visit the company's website at www.mattersight.com.
MaxLinear (NYSE: MXL) provides radio-frequency (RF) and mixed-signal circuits for broadband communications, data center, metro, and long-haul transport network applications worldwide. The company offers RF receivers and RF receiver systems-on-chips to receive and demodulate broadband signals, modem solutions, and physical medium devices that provide a constant current source, current-to-voltage regulation, and data alignment and retiming functionality in optical interconnect applications. Its products are integrated into a range of electronic devices, including cable and terrestrial and satellite set-top boxes and gates, DOCSIS data and voice gateways, hybrid analog and digital televisions, satellite low-noise blocker transponders or outdoor units, and physical medium devices. For more information, visit the company's website at www.maxlinear.com.
Maxwell Technologies (MXWL)
Maxwell Technologies (NASDAQ: MXWL) develops, manufactures and markets energy storage and power delivery products worldwide. The company offers ultra-capacitor cells, and multi-cell packs and modules, which provides energy storage and power delivery solutions for applications in various industries, including transportation, automotive, information technology, renewable energy, and industrial electronics. It also offers CONDIS high-voltage capacitors, such as grading and coupling capacitors, and electronic voltage transformers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution, and measurement of high-voltage electrical energy. For more information, visit the company's website at www.maxwell.com.
Mellanox Technologies (MLNX)
Mellanox Technologies (NASDAQ: MLNX) is a fabless semiconductor company that designs, manufactures, and sells interconnect products and solutions. Its products facilitate data transmission between servers, storage systems, communications infrastructure equipment, and other embedded systems. The company offers InfiniBand solutions, including switch and gateway integrated circuits (ICs), adapter cards, cables, modules and software, as well as switch, gateway and long-haul systems; Ethernet solution for use in enterprise data center, high-performance computing, embedded environments, hyperscale web 2.0, and cloud data centers; and Ethernet adapters. For more information, visit the company's website at www.mellanox.com.
Mesoblast (NASDAQ: MESO) develops cell-based medicines. The company has leveraged its proprietary technology platform based on specialized cells, known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular diseases, immune-mediated and inflammatory conditions, orthopedic disorders, and oncologic/hematologic conditions. Mesoblast's lead product candidates include MPC-150-IM, a phase 3 product candidate under investigation for the treatment of chronic congestive heart failure; and MPC-06-ID, a phase 3 product candidate under investigation for the treatment of chronic low back pain due to disc degeneration. For more information, visit the company's website at www.mesoblast.com.
Microbot Medical (MBOT)
Microbot Medical (NASDAQ: MBOT) is a medical device company that engages in the research, design, development, and commercialization of micro-robotics medical technologies. The company's ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel. For more information, visit the company's website at www.microbotmedical.com.
Microsemi (NASDAQ: MSCC) designs, manufactures and markets analog and mixed-signal semiconductor solutions in the United States, Europe and Asia. The company offers analog mixed-signal integrated circuits; field programmable gate arrays; system on chip solutions and application-specific integrated circuits; power management products; and timing and synchronization devices, and precise time solutions. It also provides voice processing devices, radio frequency solutions, discrete components, enterprise storage and communication solutions, security technologies and scalable anti-tamper products, Ethernet solutions, and power-over-Ethernet integrated circuits and midspans, as well as custom design capabilities and services. For more information, visit the company's website at www.microsemi.com.
Middleby (NASDAQ: MIDD) designs, manufactures, markets, distributes and services commercial foodservice, food processing and residential kitchen equipment in the United States, Canada, Asia, Europe, the Middle East and Latin America. The company's Commercial Foodservice Equipment Group segment offers cooking and warming equipment for quick-service restaurants, full-service restaurants, convenience stores, retail outlets, hotels and other institutions. The company's Food Processing Equipment Group segment offers processing solutions for customers producing pre-cooked meat products, such as hot dogs, dinner sausages, poultry and lunchmeats, as well as baked goods, including muffins, cookies and bread. For more information, visit the company's website at www.middleby.com.
Midstates Petroleum (MPO)
Midstates Petroleum (NYSE: MPO) engages in the exploration, development and production of oil, natural gas liquids, and natural gas in the United States. As of December 31, 2015, its Mississippian Lime assets consisted of approximately 69,680 net acres in the Mississippian Lime trend in Woods and Alfalfa counties of Oklahoma, as well as approximately 12,164 net acres in Lincoln County, Oklahoma; and Anadarko Basin assets consisted of approximately 111,190 net acres in the Anadarko Basin located in Texas and western Oklahoma. The company was founded in 1993 and is headquartered in Tulsa, Oklahoma. For more information, visit the company's website at www.midstatespetroleum.com.
Midwest Energy Emissions (MEEC)
Midwest Energy Emissions (OTC: MEEC) operates as an environmental services company. It focuses on the delivery of mercury capture technologies to coal-fired power plants in the United States, Canada, Europe and Asia. The company's proprietary technology delivers a flexible, tunable solution that allows the global coal-power industry to comply with new, highly restrictive regulations on mercury air emissions. It offers the least disruption to current equipment and on-going plant operations, while preserving the ability to re-cycle fly-ash for beneficial use. For more information, visit the company's website at www.midwestemissions.com.
MINDBODY (NASDAQ: MB) operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build client scheduling and online booking, staff management, client relationship management, integrated software and payments, retail point-of-sale, analytics and reporting, simple and intuitive user experience, mobility, social integration, cloud-based architecture, open platform for third-party application development, security and compliance, and integration with other cloud-based partners for yoga, Pilates, barre, indoor cycling, personal training, martial arts, and dance exercise, spas, salons, music instruction studios, dance studios, children's activity centers, and integrative health centers. For more information, visit the company's website at www.mindbodyonline.com.
Mitek Systems (MITK)
Mitek Systems (NASDAQ: MITK) develops, markets and sells mobile capture and identity verification software solutions for enterprise customers worldwide. The company applies its patented technology in image capture, correction and intelligent data extraction in the mobile financial and business services markets. Its technology allows users to remotely deposit checks, open accounts, get insurance quotes, and pay bills, as well as verify their identity by taking pictures of various documents with their camera-equipped smartphones and tablets instead of using the device keyboard. For more information, visit the company's website at www.miteksystems.com.
Model N (MODN)
Model N (NYSE: MODN) provides revenue management cloud solutions for the life science and technology industries. The company develops applications, such as managed care and government pricing for life science companies, as well as channel incentives based on design wins for technology companies. It offers Revenue Enterprise Cloud, a set of transactional applications that serve as a system of record for, and automate the execution of revenue management processes, such as pricing, contracting, compliance, incentive, and rebate management. The company also provides Revenue Intelligence Cloud, a range of intelligence applications that provide the analytical tools insights to define and optimize revenue management strategies. For more information, visit the company's website at www.modeln.com.
Mogo Finance Technology (MFTGF)
Mogo Finance Technology (OTC: MFTGF) operates as a financial technology company in Canada. The company offers its customers a way to manage their finances through its multi-product digital platform designed to help consumers get in control of their financial health. It offers access to free credit score with free monthly credit score monitoring; a digital spending account with no monthly fee accessible through a Mogo Platinum Prepaid Visa Card; and an instant pre-approval on a personal loan to consumers. The company was formerly known as Hornby Management Inc. and changed its name to Mogo Finance Technology Inc. in June 2012. For more information, visit the company's website at www.mogo.ca.
Moleculin Biotech (MBRX)
Moleculin Biotech (NASDAQ: MBRX) is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas. For more information, visit the company's website at www.moleculin.com.
Monaker Group (MKGI)
Monaker Group (OTC: MKGI) operates an online marketplace for the alternative lodging rental industry in Europe, Asia, South America, and the United States. The company provides activities and tours at the destinations for travelers through its Maupintour products, and employment solutions through NameYourFee.com website. The company was formerly known as Next 1 Interactive, Inc. and changed its name to Monaker Group, Inc. in June 2015. The company was founded in 2002 and is based in Weston, Florida. Monaker Group, Inc. is a subsidiary of Extraordinary Vacations Group Inc. For more information, visit the company's website at www.monakergroup.com.
Motorcar Parts of America (MPAA)
Motorcar Parts of America (NASDAQ: MPAA) manufactures, remanufactures and distributes aftermarket automotive parts. It offers rotating electrical products, such as alternators and starters; wheel hub assemblies and bearings; and brake master cylinders for import and domestic cars, light trucks, heavy duty, agricultural and industrial applications. The company sells its products to automotive retail outlets, OES customers, professional installers and automotive warehouse distributors, and automobile manufacturers for aftermarket programs and warranty replacement programs in North America. Motorcar Parts of America, Inc. was founded in 1968 and is headquartered in Torrance, California. For more information, visit the company's website at www.motorcarparts.com.
Naked Brand (NAKD)
Naked Brand (NASDAQ: NAKD) designs, manufactures and sells men's and women's underwear, intimate apparel, loungewear, and sleepwear products in the United States and Canada. It offers various innerwear products for men, including boxer briefs, trunks, briefs, undershirts, T-shirts, lounge pants, lounge shorts and robes, as well as loungewear and sleepwear products for women, such as boyshorts, hipsters, lounge pants and tops, camisoles, tank tops, pajamas, chemises, sleepshirts, and robes primarily under the Naked brand name. The company sells its products to consumers and retailers through wholesale channels; and direct-to-consumer channel, which consists of an online e-commerce store, wearnaked.com. For more information, visit the company's website at www.thenakedshop.com.
Nano Dimension (NNDM)
Nano Dimension (NASDAQ: NNDM) researches and develops three-dimensional (3D) printed circuit board printers. The company's 3D printers are used for printing multi-layer circuit boards. It also develops nano ink materials and products for electronics. Nano Dimension's novel and proprietary technologies enable the use of conductive and dielectric inks for ultra-rapid prototyping of complex, high-performance multilayer circuit boards. The company's PCB 3D printer is the result of combining advanced breakthroughs in inkjet technology, 3D printing and nanotechnology. Nano Dimension Ltd. was founded in 2012 and is based in Ness Ziona, Israel. For more information, visit the company's website at www.nano-di.com.
NantKwest (NASDAQ: NK) is a biotechnology company that engages in the development of immunotherapeutic agents for various clinical conditions in the United States. The company's product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in phase II clinical trials for the treatment of polyoma virus induced merkel cell carcinoma. It is also developing high-affinity natural killer product candidates primarily for the treatment of solid tumors, breast cancer, multiple myeloma, lymphoma, and colorectal cancer. For more information, visit the company's website at www.nantkwest.com.
Natus Medical (BABY)
Natus Medical (NASDAQ: BABY) designs, manufactures and markets newborn care and neurology healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography,and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. For more information, visit the company's website at www.natus.com.
Nemaska Lithium (NMX)
Nemaska Lithium (OTC: NMX) engages in the exploration and evaluation of hard rock lithium mining properties and related processing of spodumene into lithium compounds in Canada. The company owns 100% interests in the Whabouchi Property that consists of 33 claims covering an area of 1,716 hectares located in the Eeyou Istchee/James Bay area of Quebec province; and the Sirmac Property, which comprises 24 mining claims covering an area of 1,101 hectares located to the northwest of the town of Chibougamau and southeast of the town of Nemaskain Quebec province. For more information, visit the company's website at www.nemaskalithium.com.
Nemus Bioscience (NMUS)
Nemus Bioscience (OTC: NMUS) is a biopharmaceutical company focused on the discovery, development and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; and NB1222 used for treating chemotherapy induced nausea and vomiting. Its products under research comprise NB3111 for the treatment of methicillin-resistant Staphylococcus aureus, as well as NB2111 for use in treating chemotherapy induced peripheral neuropathy. The company was founded in 2012 and is headquartered in Costa Mesa, California. For more information, visit the company's website at www.nemusbioscience.com.
Neogen (NASDAQ: NEOG) develops, manufactures and markets various products and services for food and animal safety worldwide. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi and viruses. For more information, visit the company's website at www.neogen.com.
Neogenomics (NASDAQ: NEO) operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section. For more information, visit the company's website at www.neogenomics.com.
Neptune Technologies & Bioresources (NEPT)
Neptune Technologies & Bioresources (NASDAQ: NEPT) develops nutrition solutions and specialty ingredients. The company develops solutions available in various delivery forms. It also offers specialty ingredients such as premium krill oil, marine oils, and seed oils. The company sells its premium krill oil under the OCEANO3 brand directly to consumers through oceano3.com in Canada and the United States, as well as in bulk to unbranded distributors. In addition, it also researches, develops, and commercializes new krill oil-based forms of omega-3 phospholipid therapies for treatment of severe hypertriglyceridemia. For more information, visit the company's website at www.neptunecorp.com.
NeuroDerm (NASDAQ: NDRM) is a clinical-stage pharmaceutical company that engages in developing products for the treatment of central nervous system (CNS) disorders. The company's product candidates, which have completed phase IIa clinical trial, include ND0612H for the treatment of patients with severe Parkinson's disease; and ND0612L for the treatment of patients with moderate stage of Parkinson's disease. It is also developing ND0801, which is in phase IIa clinical trial for the treatment of cognition disorders associated with CNS diseases, such as ADD/ADHD, Alzheimer's disease, and schizophrenia; and ND0701, an apomorphine-based product candidate for the treatment of moderate to severe Parkinson's disease. For more information, visit the company's website at www.neuroderm.com.
New Age Beverages (NBEV)
New Age Beverages (NASDAQ: NBEV) operates as a healthy functional beverage company. It offers ready to drink tea, kombucha, energy drinks, and functional waters under XingTea, Búcha Live Kombucha, XingEnergy and Aspen Pure brand names. The company offers its products directly, as well as through store door distribution systems in the United States and internationally. It uses its brand and distribution platform to deliver healthy functional products to consumers and fuel their active lifestyles. New Age has a portfolio of four brands competing in growth segments representing over $70 million in yearly revenue. For more information, visit the company's website at www.newagebev.us.
Nouveau Monde Graphite (NMGRF)
Nouveau Monde Graphite (OTC: NMGRF) engages in the acquisition, exploration, evaluation and development of mineral properties in Quebec, Canada. It focuses on gold, graphite, and other metal deposits. The company holds interests in the Mac's Lead property with 61 mining claims covering 2,960 hectares; and the Rivière-aux-Castors property with 95 mining claims covering 4,839 hectares. The company was formerly known as Nouveau Monde Mining Enterprises Inc. and changed its name to Nouveau Monde Graphite Inc. in February 2017. The company was founded in 2011 and is based in L'Ange-Gardien, Canada. For more information, visit the company's website at www.nouveaumonde.ca.
NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals (NYSE: NBY) is a biopharmaceutical company that develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. Its commercial products include the Neutrox family of products, Avenova for the eye care market; NovaClear intelli-Case, a device for soft and rigid gas permeable contact lenses; Neutrophase for wound care; CelleRx for the dermatology market; and Aganocide compounds patented synthetic molecules with a range of spectrum of activity against bacteria, viruses, and fungi to mimic the mechanism of action against infections with a low likelihood of developing bacterial and viral resistance. For more information, visit the company's website at www.novabaypharma.com.
Novelion Therapeutics (NVLN)
Novelion Therapeutics (NASDAQ: NVLN) is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. For more information, visit the company's website at www.novelion.com.
Novogen (NASDAQ: NVGN) engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, and melanoma. Its ATM technology platform provides Anisina that destructs cancer cells cytoskeleton. The company is also developing various programs in the areas of regenerative medicine, facioscapulohumeral muscular dystrophy, and lysosomal storage disorder. For more information, visit the company's website at www.novogen.com.
NTN Buzztime (NTN)
NTN Buzztime (NYSE: NTN) provides interactive entertainment and dining technology to bars and restaurants in the United States and Canada. It licenses its customizable solution that offers guests trivia, cards, sports and arcade games, and nationwide competitions, as well as self-service dining features, including menus, touchscreen ordering, and secure payment. The company offers Buzztime Entertainment On Demand (BEOND) platform. It also engages in leasing equipment, including tablets used in its BEOND tablet platform, and cases and charging trays for the tablets to network subscribers; hosting live trivia events; and selling advertising aired on in-venue screens and as part of customized games. For more information, visit the company's website at www.buzztime.com.
Nuvectra (NASDAQ: NVTR) is a neuromodulation medical device company that develops and commercializes its neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets in Europe. The company's Algovita spinal cord stimulation system is used for the treatment of chronic pain of the trunk and limbs. It also provides neural interface technology, components, and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. The company is based in Plano, Texas. For more information, visit the company's website at www.nuvectramed.com.
NV5 Global (NVEE)
NV5 Global (NASDAQ: NVEE) provides professional and technical engineering, and consulting solutions to public and private sector clients in the infrastructure, energy, construction, real estate, and environmental markets in the United States. The company offers infrastructure, engineering and support services, including site selection, design and construction and program management in water resources, transportation, structural engineering, land development, surveying, commissioning, energy performance, power delivery and other service areas; and construction quality assurance services, such as construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting. For more information, visit the company's website at www.nv5.com.
Ocean Power Technologies (OPTT)
Ocean Power Technologies (NASDAQ: OPTT) develops and commercializes proprietary systems that generate electricity by harnessing the renewable energy of ocean waves primarily in North America, Europe, Asia, and Australia. The company offers autonomous PowerBuoy system that is designed to generate power for use independent of the power grid in remote offshore locations. The company focuses on serving public and private entities, and agencies that use electricity in the ocean. For more information, visit the company's website at www.oceanpowertechnologies.com.
Oclaro (NASDAQ: OCLR) designs, manufactures and markets lasers and optical components, modules and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company's products generate, detect, combine and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. For more information, visit the company's website at www.oclaro.com.
On Assignment (ASGN)
On Assignment (NYSE: ASGN) provides professionals for contract, contract-to-hire, and direct hire assignments primarily in the United States, Europe and Canada. The company's Apex segment offers technical, scientific and creative professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients; IT operations professionals comprising IT infrastructure, application development, project management, and healthcare IT professionals; and creative, marketing, advertising, and digital professionals. The Oxford segment recruits and delivers experienced IT, engineering, and regulatory and compliance consultants to clients for temporary assignments; provides permanent placements in engineering, technology, sales, executive, financial, accounting and offers locally-based contract and permanent life science professionals to clients in biotechnology and environmental industries. For more information, visit the company's website at www.onassignment.com.
Onconova Therapeutics (ONTX)
Onconova Therapeutics (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company that focuses on discovering and developing small molecule drug candidates to treat cancer. The company's product candidates include Rigosertib IV, which is in phase III clinical trials for patients with higher risk myelodysplastic syndromes (MDS); Rigosertib oral in combination with azacitidine that is in phase II clinical trials for patients with MDS and acute myelogenous leukemia; and Rigosertib oral, which is in phase II clinical trials for patients with lower risk MDS. Its clinical-stage product candidates also comprise Briciclib, which is in phase I multisite dose-escalation trial for patients with advanced solid tumors; and Recilisib that has completed four phase I clinical trials for patients with acute radiation syndromes. For more information, visit the company's website at www.onconova.com.
OptimizeRx (OTC: OPRX) provides technology solutions for the health care industry, offering pharmaceutical manufacturers a direct to consumer and/or direct to physician channels for communicating and promoting their products. Its products include SampleMD, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies. The company also offers OPTIMIZERx.com, a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs; and OPTIMIZEHR, which provides consulting services to pharmaceutical manufacturers for identifying, formulating, and implementing eRx media strategies for promoting their products. For more information, visit the company's website at www.optimizerx.com.
Organovo (NASDAQ: ONVO) designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The company's 3D models are developed through internal development and in collaboration with pharmaceutical, academic and other partners. Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. The company's ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing. For more information, visit the company's website at www.organovo.com.
Origin Agritech (SEED)
Origin Agritech (NASDAQ: SEED) is an agricultural biotechnology company engaged in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services in the People's Republic of China. Origin Agritech was founded in 1997 and is headquartered in the Zhong-Guan-Cun (ZGC). As the first Chinese seed company with an in-house biotech research center, Origin leads the development of Genetically Modified (GM) technology. For more information, visit the company's website at www.originseed.com.cn.
Orion Energy Systems (OESX)
Orion Energy Systems (NASDAQ: OESX) develops and markets energy management systems for the commercial office and retail, area lighting, and industrial markets in North America. The company operates in three segments: Orion U.S. Markets Division, Orion Engineered Systems Division, and Orion Distribution Services Division. It offers LED Troffer Door Retrofit for use in office or retail grid ceilings, as well as LED interior high bay lighting products consisting of Apollo class of LED interior fixtures designed for new construction and retrofit projects, as well as offers ISON class of LED interior fixtures. The company also provides Orion ISON LED exterior area fixtures; Apollo LED exterior area lights; and Apollo LED wall packs for new construction and retrofit projects. For more information, visit the company's website at www.orionlighting.com.
Ormat Technologies (ORA)
Ormat Technologies (NYSE: ORA) engages in the geothermal and recovered energy power business worldwide. The Electricity segment develops, builds, owns and operates geothermal and recovered energy-based power plants; and sells electricity. Ormat's Product segment designs, manufactures and sells equipment for geothermal and recovered energy-based electricity generation, including fossil fuel powered turbo-generators and heavy duty direct-current generators. It also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. For more information, visit the company's website at www.ormat.com.
OSI Systems (OSIS)
OSI Systems (NASDAQ: OSIS) designs, manufactures and sells electronic systems and components worldwide. The company's security segment provides baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems name. This segment also offers site design, installation, training, and technical support services; and turnkey security screening solutions under the S2 name. Its Healthcare segment provides patient monitoring, diagnostic cardiology, anesthesia delivery and ventilation systems, defibrillators, and related supplies and accessories under the Spacelabs, Primedic, and Statcorp Medical names for use in critical care, emergency, and perioperative areas within hospitals, as well as physicians' offices, medical clinics, ambulatory surgery centers, and public facilities. For more information, visit the company's website at www.osi-systems.com.
OTC Markets Group (OTCM)
OTC Markets Group (OTCQX: OTCM) operates financial markets for U.S. and global securities. The company offers OTC Link ATS that directly links a network of broker-dealers that provides liquidity and execution services for a spectrum of securities; OTC Dealer application that offers broker-dealers an interface into OTC Link ATS; and Fixie, a real-time FIX protocol that allows electronic submission and receipt of quotes, trade messages, and drop copy confirmations. It also provides Market Data Licensing business line provides investors, traders, institutions, and regulators with a suite of enterprise and user market data licenses through direct or extranet connectivity, as well as through third party market data redistributors or order management systems. For more information, visit the company's website at www.otcmarkets.com.